Hospital centralized monitoring of clinical safety of Shenkang Injection after marketing
Phase 4
- Conditions
- /A
- Registration Number
- ITMCTR2100005034
- Lead Sponsor
- The First Affiliated Hospital of He'nan University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
During the monitoring period, inpatients receiving Shenkang injection treatment in each monitoring hospital.
Exclusion Criteria
Inpatients who are unable to collect the information needed for this study.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adverse Drug Reactions/Events;
- Secondary Outcome Measures
Name Time Method